Javelin Biotech
Emily oversees the company’s internal and external scientific operations. Prior to Javelin Biotech, she was the program manager of the Translational Center of Tissue Chip Technologies (TC2T) at MIT. Her responsibilities were to coordinate the scientific projects under the PI’s scientific direction. She managed various research projects with more than $13 million in funding from NIH, CASIS, NSF, and pharmaceutical companies. Emily received her BS and MS degrees in Biomaterials and Tissue Engineering from Lehigh University and Certificate in Project Management from Bryant University.
This person is not in any offices
Javelin Biotech
Javelin Biotech creates predictive drug discovery platforms that merge human biology with computational biology to accelerate preclinical drug discovery and improve drug approval rates.